Postmenopausal Vasomotor Symptoms

• FDA approval · 2024-02-15
  FDA Approved: DIVIGEL — Supplemental Application (Vertical Pharmaceuticals, LLC)

  FDA approved a supplemental application for Divigel (estradiol transdermal gel) from Vertical Pharmaceuticals, LLC.

• FDA approval · 2017-11-01
  FDA Approved: COMBIPATCH (ESTRADIOL/NORETHINDRONE ACETATE TRANSDERMAL SYSTEM) — Supplemental Application (Noven Therapeutics, LLC)

  The FDA approved a supplemental application for COMBIPATCH, the estradiol/norethindrone acetate transdermal system, developed by Noven Thera…

• CLINICAL_TRIALS trial_result · 2014-03-26
  Clinical Trial Update: Breeze3:Study of Gabapentin Extended Release in the Treatment of Vasomotor Symptoms(Hot Flashes)in Postmenopausal Women [Phase 3]

  Phase 3 study of extended-release gabapentin for vasomotor symptoms (hot flashes) in postmenopausal women completed; results posted in 2014.

• FDA approval · 2008-04-11
  FDA Approved: EVAMIST — Supplemental Application (Padagis US LLC)

  FDA approves a supplemental NDA for EVAMIST (estradiol) by Padagis US LLC.